Tag: chemotherapy

New Investigational Helmet Device Shrinks Glioblastoma

A case report describes a novel helmet device that generates a noninvasive oscillating magnetic field and that shrunk a glioblastoma tumor by about a third....

Remote 24-Hr Monitoring Improves Life for Patients on Chemo

A remote monitoring system was highly effective in managing symptoms and improving quality of life among patients with cancer who were receiving chemotherapy, say researchers...

Remote Monitoring of Chemotherapy Patients May Help Optimize Care at Home

(Reuters Health) – Chemotherapy patients who receive remote 24-hour monitoring may have better quality of life and better control of symptoms compared to those who...

Oncologist Accused of Inappropriate Treatment ‘Provided Exceptional Care’

MANCHESTER—Leading oncologist Professor Justin Stebbing has told a medical tribunal he provided “exceptional standards of care” to a cancer patient he’s accused of giving chemotherapy...

Is Chemo Dose Too Low?

Patients with colorectal cancer (CRC) who are also obese have a poorer survival than those who are not obese. A new study suggests that they...

Kathy O’Brien, Critic of Cancer Bell Ringing, Dies at 56

Katherine O’Brien, who lived with metastatic breast cancer for 12 years and left her mark on American cancer care, died June 19 after a rapid...

FDA Approves New Asparaginase Product for Leukemia

The US Food and Drug Administration (FDA) has approved a new version of asparaginase for use in children and adults who have developed hypersensitivity to...

Hypomethylating Agents in Children With Relapsed/Refractory AML

Hypomethylating agents are generally considered to be agents of choice for older adults with acute myeloid leukemia who cannot tolerate the rigors of more intensive...

Reduced-Intensity Transplant Benefits Older Patients With AML

Among older patients with acute myeloid leukemia (AML), survival is significantly better when they undergo reduced-intensity condition (RIC) before receiving an allogeneic hematopoietic cell transplant...

Immunotherapy Likely New Standard in Advanced Esophageal Cancer

Nivolumab (Opdivo) plus chemotherapy and nivolumab plus ipilimumab (Yervoy) were superior to standard chemotherapy in improving overall survival in patients with advanced esophageal squamous cell...

No Benefit in Cervical Cancer With Adjuvant Chemo

One of the top presentations at the top cancer meeting this year has negative results — but this abstract is “very important,” says Lori J....

Olaparib in BRCA+ Breast Cancer

New clinical data show that the PARP inhibitor olaparib (Lynparza, AstraZeneca/Merck) also has a place in the treatment of early stage breast cancer with BRCA...

Immunotherapy Combo Now Approved for First-Line Mesothelioma in EU

Combination therapy with the immunotherapies nivolumab (Opdivo) and ipilimumab (Yervoy) is now approved in the European Union for the first-line treatment of adults with unresectable...

First Drug for Lung Cancer With KRAS Mutation Gains FDA Approval

The first drug to target KRAS mutations in non-small cell lung cancer (NSCLC) has been approved by the US Food and Drug Administration. KRAS mutations...

Chemoimmunotherapy in Invasive Lobular Breast Cancer

The PD-L1 inhibitor atezolizumab (Tecentriq) combined with carboplatin has shown signs of clinical activity in women with metastatic invasive lobular breast cancer (ILC) according to...

FDA OKs First Targeted Therapy for Subset of Patients With NSCLC

The US Food and Drug Administration (FDA) today granted an accelerated approval for amivantamab (Rybrevant) as the first targeted treatment for patients with non–small cell...

FDA Panel Votes Against Two Cancer Indications but Backs 4 of 6

Federal advisers this week supported the efforts of pharmaceutical companies in 4 of 6 cases in which these firms are fighting to maintain cancer indications...

Quicker Fertility Rebound in Young Women With Breast Cancer

For a young woman diagnosed with breast cancer, the prospect that the treatment needed for the cancer may irreversibly impair fertility piles on distress. A...

Pregnancy After Pioneering Treatment for Early Menopause

A novel therapy combining platelet-rich plasma (PRP) with follicle-stimulating hormone (FSH) that is injected directly into the ovaries has the potential to restore ovarian function...

Negative Results When Immunotherapy Was Added Onto Radiation

The early halt of a phase 3 trial of avelumab (Bavencio) plus chemoradiotherapy for the treatment of squamous cell head and neck cancer raises a...

Patients With Cancer Need Both Doses of COVID Vax

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The first report on responses to COVID-19 vaccination among patients with...

Weight Gain Common in Childhood Brain Tumor Survivors

Children who have been treated for brain tumors often experience significant weight gain, and new findings suggest that this could be a sign of hypothalamic-pituitary...

No Benefit Seen With Everolimus in Early Breast Cancer

Adding everolimus to adjuvant hormone therapy for early ER+, HER2- breast cancer does not offer any benefit over hormone therapy alone, according to results of...

No Survival Benefit to Primary Resection Before Chemo in CRC

NEW YORK (Reuters Health) – Contrary to previous reports, primary tumor resection prior to chemotherapy did not confer a survival benefit in colorectal cancer patients...

FDA Approves Cemiplimab-rwlc for NSCLC With PD-L1 Expression

The US Food and Drug Administration (FDA) has approved cemiplimab-rwlc (Libtayo) for the treatment of advanced non–small cell lung cancer (NSCLC). Specifically, the indication is...